Functional and molecular neuroimaging of menopause and hormone replacement therapy

Frontiers in Neuroscience

Volumn 8, Issue DEC, 2014, Pages

  Comasco, Erika ^a   Frokjaer, Vibe G ^b   Sundström Poromaa, Inger ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Mental Health Center Glostrup   (Denmark)

Author keywords

Estrogens; FMRI; Hormones; HRT; Menopause; Neuroimaging; PET; SPECT

Indexed keywords

ESTROGEN; GESTAGEN; GONADORELIN AGONIST;

BRAIN BLOOD FLOW; BRAIN FUNCTION; COGNITION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ESTROGEN THERAPY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HORMONE SUBSTITUTION; HUMAN; INFERIOR FRONTAL GYRUS; MENOPAUSE; MOLECULAR NEUROIMAGING; NEUROIMAGING; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WORKING MEMORY;

EID: 84908416848     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00388     Document Type: Review

References (120)

1. Al-Safi, Z. A., and Santoro, N. (2014). Menopausal hormone therapy and menopausal symptoms. Fertil. Steril. 101, 905-915. doi: 10.1016/j.fertnstert.2014.02.032
2. Berent-Spillson, A., Persad, C. C., Love, T., Sowers, M., Randolph, J. F., Zubieta, J. K., et al. (2012). Hormonal environment affects cognition independent of age during the menopause transition. J. Clin. Endocrinol. Metab. 97, 2012-1365. doi: 10.1210/jc.2012-1365
3. Berent-Spillson, A., Persad, C. C., Love, T., Tkaczyk, A., Wang, H., Reame, N. K., et al. (2010). Early menopausal hormone use influences brain regions used for visual working memory. Menopause 17, 692-699. doi: 10.1097/gme.0b013e3181cc49e9
4. Berman, K. F., Schmidt, P. J., Rubinow, D. R., Danaceau, M. A., Van Horn, J. D., Esposito, G., et al. (1997). Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc. Natl. Acad. Sci. U.S.A. 94, 8836-8841. doi: 10.1073/pnas.94.16.8836
5. Bethea, C. L., Reddy, A. P., Tokuyama, Y., Henderson, J. A., and Lima, F. B. (2009). Protective actions of ovarian hormones in the serotonin system of macaques. Front. Neuroendocrinol. 30, 212-238. doi: 10.1016/j.yfrne.2009.04.003
6. Biegon, A., Reches, A., Snyder, L., and McEwen, B. S. (1983). Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci. 32, 2015-2021. doi: 10.1016/0024-3205(83)90053-X
7. Birzniece, V., Johansson, I. M., Wang, M. D., Backstrom, T., and Olsson, T. (2002). Ovarian hormone effects on 5-hydroxytryptamine(2A) and 5-hydroxytryptamine(2C) receptor mRNA expression in the ventral hippocampus and frontal cortex of female rats. Neurosci. Lett. 319, 157-161. doi: 10.1016/S0304-3940(01)02570-8
8. Boccardi, M., Ghidoni, R., Govoni, S., Testa, C., Benussi, L., Bonetti, M., et al. (2006). Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study. Menopause 13, 584-591. doi: 10.1097/01.gme.0000196811.88505.10
9. Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., et al. (2008). Progesterone receptors: form and function in brain. Front. Neuroendocrinol. 29, 313-339. doi: 10.1016/j.yfrne.2008.02.001
10. Chopra, K., Misra, S., and Kuhad, A. (2011). Neurobiological aspects of Alzheimer's disease. Expert Opin. Ther. Targets 15, 535-555. doi: 10.1517/14728222.2011.557363
11. Comasco, E., Hahn, A., Ganger, S., Gingnell, M., Bannbers, E., Oreland, L., et al. (2014). Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder. Hum. Brain Mapp. 35, 4450-4458. doi: 10.1002/hbm.22486
12. Compton, J., Travis, M. J., Norbury, R., Erlandsson, K., van Amelsvoort, T., Daly, E., et al. (2008). Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study. Horm. Behav. 53, 61-68. doi: 10.1016/j.yhbeh.2007.08.014
13. Craig, M. C., Brammer, M., Maki, P. M., Fletcher, P. C., Daly, E. M., Rymer, J., et al. (2010). The interactive effect of acute ovarian suppression and the cholinergic system on visuospatial working memory in young women. Psychoneuroendocrinology 35, 987-1000. doi: 10.1016/j.psyneuen.2009.12.012
14. Craig, M. C., Cutter, W. J., Wickham, H., van Amelsvoort, T. A., Rymer, J., Whitehead, M., et al. (2004). Effect of long-term estrogen therapy on dopaminergic responsivity in post-menopausal women-a preliminary study. Psychoneuroendocrinology 29, 1309-1316. doi: 10.1016/j.psyneuen.2004.03.008
15. Craig, M. C., Daly, E. M., O'Gorman, R., Rymer, J., Lythgoe, D., Ng, G., et al. (2007a). Effects of acute ovarian hormone suppression on the human brain: an in vivo 1H MRS study. Psychoneuroendocrinology 32, 1128-1132. doi: 10.1016/j.psyneuen.2007.06.004
16. Craig, M. C., Fletcher, P. C., Daly, E. M., Picchioni, M. M., Brammer, M., Giampietro, V., et al. (2008a). A study of visuospatial working memory pre- and post-Gonadotropin Hormone Releasing Hormone agonists (GnRHa) in young women. Horm. Behav. 54, 47-59. doi: 10.1016/j.yhbeh.2008.01.012
17. Craig, M. C., Fletcher, P. C., Daly, E. M., Rymer, J., Brammer, M., Giampietro, V., et al. (2008b). Reversibility of the effects of acute ovarian hormone suppression on verbal memory and prefrontal function in pre-menopausal women. Psychoneuroendocrinology 33, 1426-1431. doi: 10.1016/j.psyneuen.2008.08.006
18. Craig, M. C., Fletcher, P. C., Daly, E. M., Rymer, J., Brammer, M., Giampietro, V., et al. (2009). The interactive effect of the cholinergic system and acute ovarian suppression on the brain: an fMRI study. Horm. Behav. 55, 41-49. doi: 10.1016/j.yhbeh.2008.08.008
19. Craig, M. C., Fletcher, P. C., Daly, E. M., Rymer, J., Cutter, W. J., Brammer, M., et al. (2007b). Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. Psychoneuroendocrinology 32, 1116-1127. doi: 10.1016/j.psyneuen.2007.09.009
20. Cyr, M., Bosse, R., and Di Paolo, T. (1998). Gonadal hormones modulate 5-hydroxytryptamine2A receptors: emphasis on the rat frontal cortex. Neuroscience 83, 829-836. doi: 10.1016/S0306-4522(97)00445-4
21. Daniel, J. M. (2013). Estrogens, estrogen receptors, and female cognitive aging: the impact of timing. Horm. Behav. 63, 231-237. doi: 10.1016/j.yhbeh.2012.05.003
22. Davis, S. R., Davison, S. L., Gavrilescu, M., Searle, K., Gogos, A., Rossell, S. L., et al. (2013). Effects of testosterone on visuospatial function and verbal fluency in postmenopausal women: results from a functional magnetic resonance imaging pilot study. Menopause 21, 410-414. doi: 10.1097/GME.0b013e3182a065ed
23. Davison, S. L., Bell, R. J., Robinson, P. J., Jane, F., Leech, J., Maruff, P., et al. (2013). Continuous-combined oral estradiol/drospirenone has no detrimental effect on cognitive performance and improves estrogen deficiency symptoms in early postmenopausal women: a randomized placebo-controlled trial. Menopause 20, 1020-1026. doi: 10.1097/GME.0b013e318287474f
24. Dumas, J. A., Albert, K. M., Naylor, M. R., Sites, C. K., Benkelfat, C., and Newhouse, P. A. (2012a). The effects of age and estrogen on stress responsivity in older women. Am. J. Geriatr. Psychiatry 20, 734-743. doi: 10.1097/JGP.0b013e31825c0a14
25. Dumas, J. A., Kutz, A. M., Naylor, M. R., Johnson, J. V., and Newhouse, P. A. (2010). Increased memory load-related frontal activation after estradiol treatment in postmenopausal women. Horm. Behav. 58, 929-935. doi: 10.1016/j.yhbeh.2010.09.003
26. Dumas, J. A., Kutz, A. M., Naylor, M. R., Johnson, J. V., and Newhouse, P. A. (2012b). Estradiol treatment altered anticholinergic-related brain activation during working memory in postmenopausal women. Neuroimage 60, 1394-1403. doi: 10.1016/j.neuroimage.2012.01.043
27. Dumas, J., Hancur-Bucci, C., Naylor, M., Sites, C., and Newhouse, P. (2006). Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacology 31, 2065-2078. doi: 10.1038/sj.npp.1301042
28. Dumas, J., Hancur-Bucci, C., Naylor, M., Sites, C., and Newhouse, P. (2008). Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm. Behav. 53, 159-169. doi: 10.1016/j.yhbeh.2007.09.011
29. Eberling, J. L., Reed, B. R., Coleman, J. E., and Jagust, W. J. (2000). Effect of estrogen on cerebral glucose metabolism in postmenopausal women. Neurology 55, 875-877. doi: 10.1212/WNL.55.6.875
30. Eberling, J. L., Wu, C., Haan, M. N., Mungas, D., Buonocore, M., and Jagust, W. J. (2003). Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol. Aging 24, 725-732. doi: 10.1016/S0197-4580(02)00056-8
31. Epperson, C. N., Amin, Z., Ruparel, K., Gur, R., and Loughead, J. (2012). Interactive effects of estrogen and serotonin on brain activation during working memory and affective processing in menopausal women. Psychoneuroendocrinology 37, 372-382. doi: 10.1016/j.psyneuen.2011.07.007
32. Epperson, C. N., Sammel, M. D., and Freeman, E. W. (2013). Menopause effects on verbal memory: findings from a longitudinal community cohort. J. Clin. Endocrinol. Metab. 98, 3829-3838. doi: 10.1210/jc.2013-1808
33. Erickson, K. I., Colcombe, S. J., Raz, N., Korol, D. L., Scalf, P., Webb, A., et al. (2005). Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy. Neurobiol. Aging 26, 1205-1213. doi: 10.1016/j.neurobiolaging.2004.11.009
34. Erickson, K. I., Voss, M. W., Prakash, R. S., Chaddock, L., and Kramer, A. F. (2010). A cross-sectional study of hormone treatment and hippocampal volume in postmenopausal women: evidence for a limited window of opportunity. Neuropsychology 24, 68-76. doi: 10.1037/a0017292
35. Espeland, M. A., Tindle, H. A., Bushnell, C. A., Jaramillo, S. A., Kuller, L. H., Margolis, K. L., et al. (2009). Brain volumes, cognitive impairment, and conjugated equine estrogens. J. Gerontol. A Biol. Sci. Med. Sci. 64, 1243-1250. doi: 10.1093/gerona/glp128
36. Freeman, E. W., Sammel, M. D., Boorman, D. W., and Zhang, R. (2014). Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry 71, 36-43. doi: 10.1001/jamapsychiatry.2013.2819
37. Freeman, E. W., Sammel, M. D., Lin, H., and Nelson, D. B. (2006). Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch. Gen. Psychiatry 63, 375-382. doi: 10.1001/archpsyc.63.4.375
38. Frey, B. N., Hall, G. B., Attard, S., Yucel, K., Skelin, I., Steiner, M., et al. (2010). Shift in the brain network of emotional regulation in midlife women: is the menopausal transition the turning point? Menopause 17, 840-845. doi: 10.1097/gme.0b013e3181df840f
39. Frokjaer, V. G., Erritzoe, D., Juul, A., Nielsen, F. A., Holst, K., Svarer, C., et al. (2010). Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding. Psychoneuroendocrinology 35, 1311-1320. doi: 10.1016/j.psyneuen.2010.03.002
40. Gardiner, S. A., Morrison, M. F., Mozley, P. D., Mozley, L. H., Brensinger, C., Bilker, W., et al. (2004). Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women. Am. J. Geriatr. Psychiatry 12, 621-630. doi: 10.1176/appi.ajgp.12.6.621
41. Gibbs, R. B. (2000). Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 101, 931-938. doi: 10.1016/S0306-4522(00)00433-4
42. Gibbs, R. B. (2010). Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr. Rev. 31, 224-253. doi: 10.1210/er.2009-0036
43. Gleason, C. E., Schmitz, T. W., Hess, T., Koscik, R. L., Trivedi, M. A., Ries, M. L., et al. (2006). Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation. Neurology 67, 2039-2041. doi: 10.1212/01.wnl.0000247277.81400.43
44. Grigorova, M., Sherwin, B. B., and Tulandi, T. (2006). Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women. Psychoneuroendocrinology 31, 935-947. doi: 10.1016/j.psyneuen.2006.05.004
45. Hafner, H. (2003). Gender differences in schizophrenia. Psychoneuroendocrinology 28(Suppl. 2), 17-54. doi: 10.1016/S0306-4530(02)00125-7
46. Hafner, H., Maurer, K., Loffler, W., and Riecher-Rossler, A. (1993). The influence of age and sex on the onset and early course of schizophrenia. Br. J. Psychiatry 162, 80-86. doi: 10.1192/bjp.162.1.80
47. Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., et al. (2012). Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause 19, 387-395. doi: 10.1097/gme.0b013e31824d8f40
48. Haugbol, S., Pinborg, L. H., Arfan, H. M., Frokjaer, V. M., Madsen, J., Dyrby, T. B., et al. (2007). Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach. Eur. J. Nucl. Med. Mol. Imaging 34, 910-915. doi: 10.1007/s00259-006-0296-y
49. Henderson, J. A., and Bethea, C. L. (2008). Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques. Endocrine 33, 285-293. doi: 10.1007/s12020-008-9087-5
50. Henderson, V. W., and Greicius, M. D. (2010). Functional magnetic resonance imaging and estrogen effects on the brain: cautious interpretation of a BOLD finding. Menopause 17, 669-671. doi: 10.1097/gme.0b013e3181e3a50e
51. Henderson, V. W., St John, J. A., Hodis, H. N., McCleary, C. A., Stanczyk, F. Z., Karim, R., et al. (2013). Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc. Natl. Acad. Sci. U.S.A. 110, 20290-20295. doi: 10.1073/pnas.1312353110
52. Hogervorst, E., Williams, J., Budge, M., Riedel, W., and Jolles, J. (2000). The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 101, 485-512. doi: 10.1016/S0306-4522(00)00410-3
53. Joffe, H., Guthrie, K. A., LaCroix, A. Z., Reed, S. D., Ensrud, K. E., Manson, J. E., et al. (2014). Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Intern. Med. 174, 1058-1066. doi: 10.1001/jamainternmed.2014.1891
54. Joffe, H., Hall, J. E., Gruber, S., Sarmiento, I. A., Cohen, L. S., Yurgelun-Todd, D., et al. (2006). Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 13, 411-422. doi: 10.1097/01.gme.0000189618.48774.7b
55. Kenna, H. A., Rasgon, N. L., Geist, C., Small, G., and Silverman, D. (2009). Thalamo-Basal Ganglia connectivity in postmenopausal women receiving estrogen therapy. Neurochem. Res. 34, 234-237. doi: 10.1007/s11064-008-9756-z
56. Kenna, H., Hoeft, F., Kelley, R., Wroolie, T., DeMuth, B., Reiss, A., et al. (2013). Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease. Neurobiol. Aging 34, 641-649. doi: 10.1016/j.neurobiolaging.2012.06.006
57. Kranz, G. S., Rami-Mark, C., Kaufmann, U., Baldinger, P., Hahn, A., Hoflich, A., et al. (2014). Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-(11)C]WAY-100635. Psychoneuroendocrinology 45, 1-10. doi: 10.1016/j.psyneuen.2014.03.004
58. Kritzer, M. F., and Kohama, S. G. (1998). Ovarian hormones influence the morphology, distribution, and density of tyrosine hydroxylase immunoreactive axons in the dorsolateral prefrontal cortex of adult rhesus monkeys. J. Comp. Neurol. 395, 1-17. doi: 10.1002/(SICI)1096-9861(19980525)395:1<1::AID-CNE1>3.0.CO;2-4
59. Kritzer, M. F., and Kohama, S. G. (1999). Ovarian hormones differentially influence immunoreactivity for dopamine beta- hydroxylase, choline acetyltransferase, and serotonin in the dorsolateral prefrontal cortex of adult rhesus monkeys. J. Comp. Neurol. 409, 438-451. doi: 10.1002/(SICI)1096-9861(19990705)409:3<438::AID-CNE8>3.0.CO;2-5
60. Kugaya, A., Epperson, C. N., Zoghbi, S., van Dyck, C. H., Hou, Y., Fujita, M., et al. (2003). Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am. J. Psychiatry 160, 1522-1524. doi: 10.1176/appi.ajp.160.8.1522
61. LeBlanc, E. S., Janowsky, J., Chan, B. K., and Nelson, H. D. (2001). Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285, 1489-1499. doi: 10.1001/jama.285.11.1489
62. Lenzenweger, M. F. (2013). Thinking clearly about the endophenotype-intermediate phenotype-biomarker distinctions in developmental psychopathology research. Dev. Psychopathol. 25, 1347-1357. doi: 10.1017/S0954579413000655
63. Lord, C., Buss, C., Lupien, S. J., and Pruessner, J. C. (2008). Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol. Aging 29, 95-101. doi: 10.1016/j.neurobiolaging.2006.09.001
64. Love, T., Smith, Y. R., Persad, C. C., Tkaczyk, A., and Zubieta, J. K. (2010). Short-term hormone treatment modulates emotion response circuitry in postmenopausal women. Fertil. Steril. 93, 1929-1937. doi: 10.1016/j.fertnstert.2008.12.056
65. Lu, N. Z., and Bethea, C. L. (2002). Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 27, 12-24. doi: 10.1016/S0893-133X(01)00423-7
66. Maki, P. M. (2013). Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. Menopause 20, 695-709. doi: 10.1097/GME.0b013e3182960cf8
67. Maki, P. M., Dennerstein, L., Clark, M., Guthrie, J., LaMontagne, P., Fornelli, D., et al. (2011). Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Res. 1379, 232-243. doi: 10.1016/j.brainres.2010.11.030
68. Maki, P. M., and Resnick, S. M. (2000). Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol. Aging 21, 373-383. doi: 10.1016/S0197-4580(00)00123-8
69. Marjoribanks, J., Farquhar, C., Roberts, H., and Lethaby, A. (2012). Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst. Rev. 7, CD004143. doi: 10.1002/14651858.CD004143.pub4
70. Meyer-Lindenberg, A., and Weinberger, D. R. (2006). Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 7, 818-827. doi: 10.1038/nrn1993
71. Moses, E. L., Drevets, W. C., Smith, G., Mathis, C. A., Kalro, B. N., Butters, M. A., et al. (2000). Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol. Psychiatry 48, 854-860. doi: 10.1016/S0006-3223(00)00967-7
72. Moses-Kolko, E. L., Berga, S. L., Greer, P. J., Smith, G., Cidis Meltzer, C., and Drevets, W. C. (2003). Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women. Fertil. Steril. 80, 554-559. doi: 10.1016/S0015-0282(03)00973-7
73. Mueller, S. C., Grissom, E. M., and Dohanich, G. P. (2014). Assessing gonadal hormone contributions to affective psychopathologies across humans and animal models. Psychoneuroendocrinology 46C, 114-128. doi: 10.1016/j.psyneuen.2014.04.015
74. Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., and Allan, J. D. (2002). Postmenopausal hormone replacement therapy: scientific review. JAMA 288, 872-881. doi: 10.1001/jama.288.7.872
75. Newhouse, P. A., Dumas, J., Hancur-Bucci, C., Naylor, M., Sites, C. K., Benkelfat, C., et al. (2008). Estrogen administration negatively alters mood following monoaminergic depletion and psychosocial stress in postmenopausal women. Neuropsychopharmacology 33, 1514-1527. doi: 10.1038/sj.npp.1301530
76. Newhouse, P. A., Dumas, J., Wilkins, H., Coderre, E., Sites, C. K., Naylor, M., et al. (2010). Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women. Menopause 17, 860-873. doi: 10.1097/gme.0b013e3181e15df4
77. Norbury, R., Travis, M. J., Erlandsson, K., Waddington, W., Ell, P. J., and Murphy, D. G. (2007). Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study. Horm. Behav. 51, 249-257. doi: 10.1016/j.yhbeh.2006.10.007
78. Ohkura, T., Teshima, Y., Isse, K., Matsuda, H., Inoue, T., Sakai, Y., et al. (1995). Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. J. North Am. Menopause Soc. 2, 13-18.
79. Owens, J. F., Matthews, K. A., and Everson, S. A. (2002). Cognitive function effects of suppressing ovarian hormones in young women. Menopause 9, 227-235. doi: 10.1097/00042192-200207000-00003
80. Persad, C. C., Zubieta, J. K., Love, T., Wang, H., Tkaczyk, A., and Smith, Y. R. (2009). Enhanced neuroactivation during verbal memory processing in postmenopausal women receiving short-term hormone therapy. Fertil. Steril. 92, 197-204. doi: 10.1016/j.fertnstert.2008.04.040
81. Pruis, T. A., Roalf, D. R., and Janowsky, J. S. (2009). Hormone therapy does not modify emotion-induced brain activity in older women. Horm. Behav. 56, 539-547. doi: 10.1016/j.yhbeh.2009.09.008
82. Rasetti, R., and Weinberger, D. R. (2011). Intermediate phenotypes in psychiatric disorders. Curr. Opin. Genet. Dev. 21, 340-348. doi: 10.1016/j.gde.2011.02.003
83. Rasgon, N. L., Geist, C. L., Kenna, H. A., Wroolie, T. E., Williams, K. E., and Silverman, D. H. (2014). Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia. PLoS ONE 9:e89095. doi: 10.1371/journal.pone.0089095
84. Rasgon, N. L., Silverman, D., Siddarth, P., Miller, K., Ercoli, L. M., Elman, S., et al. (2005). Estrogen use and brain metabolic change in postmenopausal women. Neurobiol Aging 26, 229-235. doi: 10.1016/j.neurobiolaging.2004.03.003
85. Rasgon, N. L., Small, G. W., Siddarth, P., Miller, K., Ercoli, L. M., Bookheimer, S. Y., et al. (2001). Estrogen use and brain metabolic change in older adults. A preliminary report. Psychiatry Res. 107, 11-18. doi: 10.1016/S0925-4927(01)00084-1
86. Resnick, S. M., Maki, P. M., Golski, S., Kraut, M. A., and Zonderman, A. B. (1998). Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm. Behav. 34, 171-182. doi: 10.1006/hbeh.1998.1476
87. Riecher-Rössler, A., and Kulkarni, J. (2011). "Biological basis of sex differences in psychopharmacology," in Current Topics in Behavioral Neurosciences, eds J. C. Neill and J. Kulkarni (Berlin; Heidelberg: Springer-Verlag), v-vii.
88. Robertson, D. M., van Amelsvoort, T., Daly, E., Simmons, A., Whitehead, M., Morris, R. G., et al. (2001). Effects of estrogen replacement therapy on human brain aging: an in vivo 1H MRS study. Neurology 57, 2114-2117. doi: 10.1212/WNL.57.11.2114
89. Rocca, W. A., Grossardt, B. R., and Shuster, L. T. (2014). Oophorectomy, estrogen, and dementia: a 2014 update. Mol. Cell. Endocrinol. 389, 7-12. doi: 10.1016/j.mce.2014.01.020
90. Sanchez, M. G., Morissette, M., and Di Paolo, T. (2013). Oestradiol modulation of serotonin reuptake transporter and serotonin metabolism in the brain of monkeys. J. Neuroendocrinol. 25, 560-569. doi: 10.1111/jne.12034
91. Shafir, T., Love, T., Berent-Spillson, A., Persad, C. C., Wang, H., Reame, N. K., et al. (2012). Postmenopausal hormone use impact on emotion processing circuitry. Behav. Brain Res. 226, 147-153. doi: 10.1016/j.bbr.2011.09.012
92. Shaywitz, S. E., Shaywitz, B. A., Pugh, K. R., Fulbright, R. K., Skudlarski, P., Mencl, W. E., et al. (1999). Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 281, 1197-1202. doi: 10.1001/jama.281.13.1197
93. Sherwin, B. B., and Henry, J. F. (2008). Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front. Neuroendocrinol. 29, 88-113. doi: 10.1016/j.yfrne.2007.08.002
94. Sherwin, B. B., and Tulandi, T. (1996). "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J. Clin. Endocrinol. Metab. 81, 2545-2549.
95. Shively, C. A., and Bethea, C. L. (2004). Cognition, mood disorders, and sex hormones. ILAR J. 45, 189-199. doi: 10.1093/ilar.45.2.189
96. Silverman, D. H., Geist, C. L., Kenna, H. A., Williams, K., Wroolie, T., Powers, B., et al. (2011). Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD. Psychoneuroendocrinology 36, 502-513. doi: 10.1016/j.psyneuen.2010.08.002
97. Slopien, R., Junik, R., Meczekalski, B., Halerz-Nowakowska, B., Maciejewska, M., Warenik-Szymankiewicz, A., et al. (2003). Influence of hormonal replacement therapy on the regional cerebral blood flow in postmenopausal women. Maturitas 46, 255-262. doi: 10.1016/S0378-5122(03)00144-0
98. Smith, Y. R., Bowen, L., Love, T. M., Berent-Spillson, A., Frey, K. A., Persad, C. C., et al. (2011). Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity. J. Clin. Endocrinol. Metab. 96, E1761-E1770. doi: 10.1210/jc.2011-0351
99. Smith, Y. R., Love, T., Persad, C. C., Tkaczyk, A., Nichols, T. E., and Zubieta, J. K. (2006). Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. J. Clin. Endocrinol. Metab. 91, 4476-4481. doi: 10.1210/jc.2006-0907
100. Smith, Y. R., Minoshima, S., Kuhl, D. E., and Zubieta, J. K. (2001). Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J. Clin. Endocrinol. Metab. 86, 679-684. doi: 10.1210/jcem.86.2.7222
101. Soares, C. N. (2013). Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management. Drugs Aging 30, 677-685. doi: 10.1007/s40266-013-0100-1
102. Stein, P., Baldinger, P., Kaufmann, U., Christina, R. M., Hahn, A., Hoflich, A., et al. (2014). Relation of progesterone and DHEAS serum levels to 5-HT1A receptor binding potential in pre- and postmenopausal women. Psychoneuroendocrinology 46, 52-63. doi: 10.1016/j.psyneuen.2014.04.008
103. Sumner, B. E., and Fink, G. (1997). The density of 5-hydoxytryptamine2A receptors in forebrain is increased at pro-oestrus in intact female rats. Neurosci. Lett. 234, 7-10. doi: 10.1016/S0304-3940(97)00651-4
104. Sumner, B. E., and Fink, G. (1998). Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain. Brain Res. Mol. Brain Res. 59, 205-214. doi: 10.1016/S0169-328X(98)00148-X
105. Sumner, B. E., Grant, K. E., Rosie, R., Hegele-Hartung, C., Fritzemeier, K. H., and Fink, G. (1999). Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Res. Mol. Brain Res. 73, 119-128. doi: 10.1016/S0169-328X(99)00243-0
106. Sumner, B. E., Grant, K. E., Rosie, R., Hegele-Hartung, C., Fritzemeier, K. H., and Fink, G. (2007). Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain. Neurosci. Lett. 417, 95-99. doi: 10.1016/j.neulet.2007.02.039
107. Tayebati, S. K., and Amenta, F. (2013). Choline-containing phospholipids: relevance to brain functional pathways. Clin. Chem. Lab. Med. 51, 513-521. doi: 10.1515/cclm-2012-0559
108. Tinkler, G. P., Tobin, J. R., and Voytko, M. L. (2004). Effects of two years of estrogen loss or replacement on nucleus basalis cholinergic neurons and cholinergic fibers to the dorsolateral prefrontal and inferior parietal cortex of monkeys. J. Comp. Neurol. 469, 507-521. doi: 10.1002/cne.11028
109. Toffol, E., Heikinheimo, O., and Partonen, T. (2013). Associations between psychological well-being, mental health, and hormone therapy in perimenopausal and postmenopausal women: results of two population-based studies. Menopause 20, 667-676. doi: 10.1097/gme.0b013e318278eec1
110. Toffoletto, S., Lanzenberger, R., Gingnell, M., Sundstrom-Poromaa, I., and Comasco, E. (2014). Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: A systematic review. Psychoneuroendocrinology 50C, 28-52. doi: 10.1016/j.psyneuen.2014.07.025
111. Voytko, M. L. (2002). Estrogen and the cholinergic system modulate visuospatial attention in monkeys (Macaca fascicularis). Behav. Neurosci. 116, 187-197. doi: 10.1037/0735-7044.116.2.187
112. Voytko, M. L., Tinkler, G. P., Browne, C., and Tobin, J. R. (2009). Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause. Am. J. Primatol. 71, 794-801. doi: 10.1002/ajp.20705
113. Wharton, W., Gleason, C. E., Olson, S. R., Carlsson, C. M., and Asthana, S. (2012). Neurobiological underpinnings of the estrogen - mood relationship. Curr. Psychiatry Rev. 8, 247-256. doi: 10.2174/157340012800792957
114. Wihlback, A. C., Sundstrom-Poromaa, I., Allard, P., Mjorndal, T., Spigset, O., and Backstrom, T. (2001). Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding. Obstet. Gynecol. 98, 450-457. doi: 10.1016/S0029-7844(01)01461-2
115. Wnuk, A., Korol, D. L., and Erickson, K. I. (2012). Estrogens, hormone therapy, and hippocampal volume in postmenopausal women. Maturitas 73, 186-190. doi: 10.1016/j.maturitas.2012.07.001
116. Yaffe, K., Lindquist, K., Sen, S., Cauley, J., Ferrell, R., Penninx, B., et al. (2009). Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study. Neurobiol. Aging 30, 607-614. doi: 10.1016/j.neurobiolaging.2007.08.003
117. Yaffe, K., Lui, L. Y., Grady, D., Stone, K., and Morin, P. (2002). Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol. Psychiatry 51, 677-682. doi: 10.1016/S0006-3223(01)01289-6
118. Yaffe, K., Sawaya, G., Lieberburg, I., and Grady, D. (1998). Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279, 688-695. doi: 10.1001/jama.279.9.688
119. Yue, Y., Hu, L., Tian, Q. J., Jiang, J. M., Dong, Y. L., Jin, Z. Y., et al. (2007). Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes. Acta Pharmacol. Sin. 28, 1129-1135. doi: 10.1111/j.1745-7254.2007.00618.x
120. Zweifel, J. E., and O'Brien, W. H. (1997). A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22, 189-212. doi: 10.1016/S0306-4530(96)00034-0